Latest Mipomersen Stories
- Isis Outperforms 2014 Projections for Pro Forma Net Operating Loss and Year-end Cash CARLSBAD, Calif., Feb. 27, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
AstraZeneca advances ISIS-STAT3 Rx in Clinical Development CARLSBAD, Calif., Nov. 5, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
-Conference Call Webcast Tuesday, May 6, 11:30 a.m. ET at www.isispharm.com CARLSBAD, Calif., May 6, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.